“…-25,27,28,30,31,33,35-46,48,49,51,60-62 and 5[20][21][22][23][24]27,28,30,31,35,[41][42][43]46,47,49,54,55,[62][63][64][65][66][67][68][69][70][71][72] .…”
The model offers new insights for immunization policy. We measured the mucosal immunogenicity of IPV to a precision that is useful in decision-making for end-game polio immunization policies.
“…-25,27,28,30,31,33,35-46,48,49,51,60-62 and 5[20][21][22][23][24]27,28,30,31,35,[41][42][43]46,47,49,54,55,[62][63][64][65][66][67][68][69][70][71][72] .…”
The model offers new insights for immunization policy. We measured the mucosal immunogenicity of IPV to a precision that is useful in decision-making for end-game polio immunization policies.
“…Thus members of 20 percent of the households in the village were fed vaccine (group B), and stool specimens were available from an additional 20 percent as con¬ trols for measuring the community spread of the vaccine strains. A map showing the distri¬ bution of vaccine and placebo fed households has been published (6). There were 545 per¬ sons in the 149 study families; 266 in group B, the vaccine-fed group, and 279 in group A, the placebo-fed, or control, group.…”
Section: Methodsmentioning
confidence: 99%
“…The first specimens were collected prior to the feeding of vaccine to either group. The second, third, and fourth specimens were collected after type 2 virus had been fed to group B and before it was fed to group A; the third, fourth, and fifth specimens, after type 1 had been fed to group B and before it was fed to group A; and the fourth, fifth, and sixth specimens after type 3 had been fed to group B and before it was fed to group A. Thus three stool specimens were available to measure the community spread of each type of poliovirus, and this spread was measured for a period of about 8 weeks for each type.…”
Section: Methodsmentioning
confidence: 99%
“…Criteria used in evaluating the illnesses ob¬ served in group A, the placebo-fed individuals who acquired the vaccine strains by natural passage, are presented with "Results." The medical followup was continuous and included numerous house visits (1).…”
Section: Methodsmentioning
confidence: 99%
“…Poliovirus was not isolated from any adults or children with antibodies detectable in serum dilution 1:4 unless the individual was known to have received Salk vaccine. Virus isolation rates from stool specimens as a function of anti¬ body status on the initial blood specimen and Salk vaccine experience is shown in table 6. Among the adults the majority, 63 percent or more, had poliomyelitis antibodies detectable in serum dilution 1:4 or greater in the initial specimen, but virus isolation was accomplished from few of these individuals compared with the isolation rates from those without anti¬ bodies.…”
A STUDY of orally administered attenuated poliovirus vaccine was conducted in a small community in Minnesota in 1958. In that study (1), the feeding of virus to only half of the participating families during the first half of the study provided an opportunity to study the spread of these strains of poliovirus to par¬ ticipants who received placebos. Prior to this study, intrafamily (2-4) and intrainstitutional (5) spread of attenuated poliomyelitis vaccine viruses had been reported. This study presents quantitative data on the community spread of vaccine strains of polio¬ virus. The design of the study, the vaccine strains used, the characteristics of the study population, the illnesses observed during the study, and the method of surveillance used to detect such illnesses were described in the earlier report (1).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.